Lurasidone in the long-term treatment of Japanese patients with bipolar I disorder: a 52 week open label study

BACKGROUND: The current study evaluated the long-term (52 week) safety and impact on symptom measures of lurasidone (with or without lithium or valproate) for the treatment of bipolar I disorder in Japanese patients. METHODS: Bipolar patients for this open-label flexibly dosed lurasidone (20–120 mg/...

Descripción completa

Detalles Bibliográficos
Autores principales: Higuchi, Teruhiko, Kato, Tadafumi, Miyajima, Mari, Watabe, Kei, Masuda, Takahiro, Hagi, Katsuhiko, Ishigooka, Jun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8333182/
https://www.ncbi.nlm.nih.gov/pubmed/34342746
http://dx.doi.org/10.1186/s40345-021-00230-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8333182/
https://www.ncbi.nlm.nih.gov/pubmed/34342746
http://dx.doi.org/10.1186/s40345-021-00230-8

Ejemplares similares